• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯艾哈萨地区镰状细胞病患者的血液学特征

Hematological Characteristics of Patients With Sickle Cell Disease in Al Ahsa, Saudi Arabia.

作者信息

Al Khamees Mohammad H, AlAlwan Bader, Al Saleh Mohammed, Alqurain Aymen A, Bu-Kheder Mohammed S, Bin Khalaf Habeeb K, Al Fenes Yahya A, Alkhadhrawi Baqer, Al Hajji Abdulhadi, Alsafar Nida

机构信息

Laboratory Medicine, King Fahad General Hospital, Al Hofuf, SAU.

Laboratory Medicine, Mohammed Al-Mana College for Medical Sciences, Dammam, SAU.

出版信息

Cureus. 2025 Jul 7;17(7):e87432. doi: 10.7759/cureus.87432. eCollection 2025 Jul.

DOI:10.7759/cureus.87432
PMID:40772168
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12327378/
Abstract

Sickle cell disease (SCD) is an autosomal recessive illness characterized by severe morbidity and mortality rates. Although numerous studies on SCD have been conducted worldwide, the hematological features of SCD in the Middle East require further investigation. Therefore, we conducted this study to examine the hematological characteristics of SCD in Saudi Arabia, specifically in the Al Ahsa region. We performed a retrospective examination of health records at King Fahad Hospital in Hofuf, and data were analyzed in relation to gender, age, and other demographic factors. This study included a total of 96 records, with an average age of patients being 33 years. The majority of the patients (60%) were male. Most of the patients were anemic (99%), with one-quarter (26%) suffering from mild-to-moderate anemia (hemoglobin (Hb) above 10 g/dL) and the remaining three-quarters (74%) suffering from severe anemia (Hb below 10 g/dL). Correlation studies show that older patients (above 50 years old) are more severely affected by the disease compared to younger adult groups, evidenced by a strong negative correlation between age and both Hb levels and red blood cell counts (RBCs). Severe anemia is more common in females than in males, with a mean Hb of 8.4 g/dL in females (79% having Hb below 10 g/dL) compared to a mean Hb of 9.0 g/dL in males (71% having Hb below 10 g/dL). About half of the studied SCD population showed abnormal platelet counts (51%), with no significant difference between males and females. Thrombocytosis was slightly more prevalent than thrombocytopenia (31% vs. 20%). Our study indicates that SCD in Al Ahsa, Saudi Arabia, is associated with moderate-to-severe anemia. The impact of the disease is more pronounced in older individuals and females. Abnormal platelet counts are common among SCD patients in the Al Ahsa region. These findings should be taken into account when addressing SCD in the eastern province of Saudi Arabia and possibly in other regions.

摘要

镰状细胞病(SCD)是一种常染色体隐性疾病,其特点是发病率和死亡率都很高。尽管全球范围内已经开展了大量关于SCD的研究,但中东地区SCD的血液学特征仍需进一步研究。因此,我们开展了这项研究,以检查沙特阿拉伯特别是艾哈萨地区SCD的血液学特征。我们对胡富夫法赫德国王医院的健康记录进行了回顾性检查,并根据性别、年龄和其他人口统计学因素对数据进行了分析。本研究共纳入96份记录,患者的平均年龄为33岁。大多数患者(60%)为男性。大多数患者患有贫血(99%),其中四分之一(26%)患有轻度至中度贫血(血红蛋白(Hb)高于10 g/dL),其余四分之三(74%)患有重度贫血(Hb低于10 g/dL)。相关性研究表明,与年轻成年人群体相比,老年患者(50岁以上)受该疾病的影响更严重,年龄与Hb水平和红细胞计数(RBC)之间存在强烈的负相关关系,这证明了这一点。重度贫血在女性中比在男性中更常见,女性的平均Hb为8.4 g/dL(79%的女性Hb低于10 g/dL),而男性的平均Hb为9.0 g/dL(71%的男性Hb低于10 g/dL)。在研究的SCD人群中,约一半(51%)的血小板计数异常,男性和女性之间无显著差异。血小板增多症比血小板减少症略为常见(31%对20%)。我们的研究表明,沙特阿拉伯艾哈萨地区的SCD与中度至重度贫血有关。该疾病的影响在老年人和女性中更为明显。艾哈萨地区的SCD患者中血小板计数异常很常见。在沙特阿拉伯东部省份以及可能在其他地区处理SCD问题时,应考虑这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60c/12327378/43a841b67953/cureus-0017-00000087432-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60c/12327378/a389aac92d3c/cureus-0017-00000087432-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60c/12327378/238ede57c8c5/cureus-0017-00000087432-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60c/12327378/e4874479d6a4/cureus-0017-00000087432-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60c/12327378/43a841b67953/cureus-0017-00000087432-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60c/12327378/a389aac92d3c/cureus-0017-00000087432-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60c/12327378/238ede57c8c5/cureus-0017-00000087432-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60c/12327378/e4874479d6a4/cureus-0017-00000087432-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60c/12327378/43a841b67953/cureus-0017-00000087432-i04.jpg

相似文献

1
Hematological Characteristics of Patients With Sickle Cell Disease in Al Ahsa, Saudi Arabia.沙特阿拉伯艾哈萨地区镰状细胞病患者的血液学特征
Cureus. 2025 Jul 7;17(7):e87432. doi: 10.7759/cureus.87432. eCollection 2025 Jul.
2
Sickle Cell Disease镰状细胞病
3
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
4
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
5
Antioxidant supplementation for sickle cell disease.抗氧化剂补充治疗镰状细胞病。
Cochrane Database Syst Rev. 2024 May 22;5(5):CD013590. doi: 10.1002/14651858.CD013590.pub2.
6
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
7
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3.
8
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
9
Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.针对患者及护理人员的干预措施,以提高对镰状细胞病的认识及其相关并发症的识别能力。
Cochrane Database Syst Rev. 2016 Oct 6;10(10):CD011175. doi: 10.1002/14651858.CD011175.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Understanding Sickle cell disease: Causes, symptoms, and treatment options.了解镰状细胞病:病因、症状和治疗选择。
Medicine (Baltimore). 2023 Sep 22;102(38):e35237. doi: 10.1097/MD.0000000000035237.
2
Sickle Cell Disease: From Genetics to Curative Approaches.镰状细胞病:从遗传学角度到治疗方法。
Annu Rev Genomics Hum Genet. 2023 Aug 25;24:255-275. doi: 10.1146/annurev-genom-120122-081037.
3
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021.
全球、区域和国家镰状细胞病的患病率和死亡负担,2000-2021 年:2021 年全球疾病负担研究的系统分析。
Lancet Haematol. 2023 Aug;10(8):e585-e599. doi: 10.1016/S2352-3026(23)00118-7. Epub 2023 Jun 15.
4
Genotypic and Phenotypic Composition of Sickle Cell Disease in the Arab Population - A Systematic Review.阿拉伯人群中镰状细胞病的基因型和表型组成——一项系统综述
Pharmgenomics Pers Med. 2023 Feb 21;16:133-144. doi: 10.2147/PGPM.S391394. eCollection 2023.
5
Severe Maternal Morbidity and Mortality in Sickle Cell Disease in the National Inpatient Sample, 2012-2018.2012-2018 年全国住院患者样本中镰状细胞病的严重孕产妇发病率和死亡率。
JAMA Netw Open. 2023 Feb 1;6(2):e2254552. doi: 10.1001/jamanetworkopen.2022.54552.
6
The Burden of Sickle Cell Disease in Saudi Arabia: A Single-Institution Large Retrospective Study.沙特阿拉伯镰状细胞病的负担:一项单机构大型回顾性研究
Int J Gen Med. 2023 Jan 13;16:161-171. doi: 10.2147/IJGM.S393233. eCollection 2023.
7
The Prevalence of Depression and Anxiety Among Sickle Cell Disease Patients in King Abdulaziz University Hospital.阿卜杜勒阿齐兹国王大学医院镰状细胞病患者中抑郁症和焦虑症的患病率
Cureus. 2021 Sep 29;13(9):e18374. doi: 10.7759/cureus.18374. eCollection 2021 Sep.
8
Co-morbidities and mortality in patients with sickle cell disease in England: A 10-year cohort analysis using hospital episodes statistics (HES) data.英国患有镰状细胞病患者的合并症和死亡率:使用医院病例统计数据(HES)的 10 年队列分析。
Blood Cells Mol Dis. 2021 Jul;89:102567. doi: 10.1016/j.bcmd.2021.102567. Epub 2021 Apr 1.
9
Sickle Cell Disease-Genetics, Pathophysiology, Clinical Presentation and Treatment.镰状细胞病——遗传学、病理生理学、临床表现与治疗
Int J Neonatal Screen. 2019 May 7;5(2):20. doi: 10.3390/ijns5020020. eCollection 2019 Jun.
10
Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.沙特阿拉伯的镰状细胞病:具有阿拉伯-印度单倍型的成年人的表型并非良性。
Br J Haematol. 2014 Feb;164(4):597-604. doi: 10.1111/bjh.12650. Epub 2013 Nov 13.